Findings of 18 F-PI-2620 tau PET imaging in patients with Alzheimer's disease and healthy controls in relation to the plasma P-tau181 levels in a Japanese sample.
Shogyoku BunSho MoriguchiToshiki TezukaYoshiaki SatoKeisuke TakahataMorinobu SekiShinichiro NakajimaYasuharu YamamotoYasunori SanoNatsumi SuzukiAyaka MorimotoRyo UedaHajime TabuchiDaisuke ItoMasaru MimuraPublished in: Neuropsychopharmacology reports (2022)
F-PI-2620 is a promising tau PET tracer that allows patients with AD to be distinguished from healthy controls, although a study with a larger sample size is warranted.